Skip to main content

Advertisement

SpringerLink
Log in

Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single centre cohort with a long follow-up

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897–904.

    Article  CAS  Google Scholar 

  2. Bhatia S, Louie AD, Bhatia R, O’Donnell MR, Fung H, Kashyap A, et al. Solid cancers after bone marrow transplantation. J Clin Oncol. 2001;19:464–71.

    Article  CAS  Google Scholar 

  3. Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E, Landgren O, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009;113:1175–83.

    Article  CAS  Google Scholar 

  4. Shimoni A, Shem-Tov N, Chetrit A, Volchek Y, Tallis E, Avigdor A, et al. Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced. Leukemia. 2013;27:829–35.

    Article  CAS  Google Scholar 

  5. Kolb HJ, Socie G, Duell T, Van Lint MT, Tichelli A, Apperley JF, et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med. 1999;131:738–44.

    Article  CAS  Google Scholar 

  6. Tanaka Y, Kurosawa S, Tajima K, Tanaka T, Ito R, Inoue Y, et al. Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52:789–91.

    Article  CAS  Google Scholar 

  7. Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant. 2005;36:115–21.

    Article  CAS  Google Scholar 

  8. Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE. Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016;51:83–88.

    Article  CAS  Google Scholar 

  9. Ringden O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, et al. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol Blood Marrow Transplant. 2014;20:1777–84.

    Article  Google Scholar 

  10. Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, et al. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood. 2011;117:316–22.

    Article  CAS  Google Scholar 

  11. Abou-Mourad YR, Lau BC, Barnett MJ, Forrest DL, Hogge DE, Nantel SH, et al. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens. Bone Marrow Transplant. 2010;45:295–302.

    Article  CAS  Google Scholar 

  12. Baker KS, DeFor TE, Burns LJ, Ramsay NKC, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol. 2003;21:1352–8.

    Article  Google Scholar 

  13. Gunnarsson N, Stenke L, Hoglund M, Sandin F, Bjorkholm M, Dreimane A, et al. Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era. Br J Haematol. 2015;169:683–8.

    Article  CAS  Google Scholar 

  14. Gunnarsson N, Hoglund M, Stenke L, Wallberg-Jonsson S, Sandin F, Bjorkholm M, et al. Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia. Leukemia. 2016;30:1562–7.

    Article  CAS  Google Scholar 

  15. Frederiksen H, Farkas DK, Christiansen CF, Hasselbalch HC, Sorensen HT. Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study. Blood. 2011;118:6515–20.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank EBMT registry co-ordinator Mrs. Marja Pekkanen for the data collection. This study was supported by the Blood Diseases Research Foundation, Helsinki, Finland.

This study is compliant with the ethical standards of the Declaration of Helsinki.

Author information

Authors and Affiliations

  1. Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and Helsinki University, Helsinki, Finland

    Eeva Martelin, Liisa Volin, Maija Itälä-Remes, Riitta Niittyvuopio, Vesa Lindström, Jouni Heiskanen, Tapani Ruutu & Anne Nihtinen

Authors
  1. Eeva Martelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liisa Volin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maija Itälä-Remes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Riitta Niittyvuopio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vesa Lindström
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jouni Heiskanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tapani Ruutu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Anne Nihtinen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eeva Martelin.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

The authors have nothing to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martelin, E., Volin, L., Itälä-Remes, M. et al. Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single centre cohort with a long follow-up. Bone Marrow Transplant 54, 334–337 (2019). https://doi.org/10.1038/s41409-018-0290-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-018-0290-6

  • Springer Nature Limited

This article is cited by

Search

Navigation